Indications and uses
Uses: SUNBURN PROTECTANT SPF 50. PROTECTS AGAINST UVA/UVB RAYS.
BritePrep FX
- Manufacturer
- Cover FX Skin Care, Inc.
- Effective date
- 2013-02-19
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:34:37
Label at a glance#
ProductBritePrep FX
Active ingredientOCTOCRYLENE, OCTINOXATE, OXYBENZONE, TITANIUM DIOXIDE
Label structure9 sections
Dosage and administration
DIRECTIONS: APPLY PRIOR TO SUN EXPOSURE SHAKE WELL BEFORE USE
Contacts and useful links#
Websitewww.sfiprogram.org
www.sfiprogram.org
www.sfiprogram.orgWebsitewww.coverfx.com
WWW.COVERFX.COM
WWW.COVERFX.COMLabel contents#
Full prescribing information#
Active Ingredient Section
ACTIVE INGREDIENTS: OCTOCRYLENE - 9.0% w/w, OCTINOXATE 7.5% w/w, OXYBENZONE 3.0% w/w, TITANIUM DIOXIDE 1.5% w/w
Purpose Section
BRIGHTENING FOUNDATION PRIMER SPF 50
PRIME YOUR SKIN WITH THIS CREAM BALM PRIMER, TO IMPROVE BLENDING AND WEAR. DERMAVEIL BLURS THE APPEARANCE OF FINE LINES AND PORES, WHILE ILLUMINATING SKIN. BEARBERRY EXTRACT HELPS REDUCE THE APPEARANCE OF AGE SPOTS BY BRIGHTENING THE SKIN. TEPRENONE AND PEPTIDES PROMOTES YOUTHFUL LOOKINGSKIN. SWEET BLACK TEA MOISTURIZES THE SKIN TO LOOK STRENGTHENED, FIRM AND PLUMP.
Warnings Section
THE SUN MAY CAUSE SUNBURN, PREMATURE AGING OF THE SKIN AND SKIN CANCER. AVOIDING THE SUN, WEARING PROTECTIVE CLOTHING AND THE REGULAR USE OF SUNSCREENS OVER THE YEARS MAY REDUCE THE CHANCE OF THESE HARMFUL EFFECTS.
WARNINGS: CONTAINS BENZOPHENONE - 3
CAUTION: DISCONTINUE USE IF SKIN IRRITATION DEVELOPS OR INCREASES. IF IRRITATION PERSISTS, CONSULT A HEALTH CARE PRACTITIONER.
Report Section
YOU MAY REPORT A SERIOUS ADVERSE AFFECT FROM USE OF THIS PRODUCT TO (USA) COVER FX, 33 ELM STREET, SUITE 377, CHAMPLAIN, NY 12919 9CANADA) COVER FX, 1681 FLINT RD, TORONTO, ON M3J 2W8
Keep Out of Reach of Children Section
Enter section text here
Uses Section
Uses: SUNBURN PROTECTANT SPF 50. PROTECTS AGAINST UVA/UVB RAYS.
Directions Section
DIRECTIONS: APPLY PRIOR TO SUN EXPOSURE
SHAKE WELL BEFORE USE
Inactive Ingredients Section
INACTIVE INGREDIENTS: CYCLOPENTASILOXANE, AQUA, HYDROGENATED POLYISOBUTENE, GLYCERIN, POLYETHYLENE, CAPRYLIC/CAPRIC TRIGLYCERITE, C12-15 ALKYL BENZOATE, SACCHAROMYCES/XYLINUM BLACK TEA FERMENT, SILICA, DIMETHICONE CROSSPOLYMER, CETYL PEG/PPG-10/1 DIMETHICONE, SQUALANE, MICA, GLYCERYL DIBEHENATE, ALOE BARBADENSIS LEAF JUICE, ASCORBYL GLUCOSIDE, BISABOLOL, BUTYROSPERMUM PARKII (SHEA BUTTER), CETYL DIMETHICONE, OCTADCENEDIOIC ACID, TOCOPHERYL ACETATE, TITANIUM DIOXIDE, SODIUM CHLORIDE, BUTYLENE GLYCOL, TRIBEHENIN, DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER, TIN OXIDE, ALUMINA, ARCTOSTAPHYLOS UVA URSI (BEARBERRY) EXTRACT, DIMETHICONOL, ISOPROPYL TITANIUM TRIISOSTEARATE/TRIETHOXYCARYLYLSILANE CROSSPOLYMER, POLYHYDROXYSTEARIC ACID, BENZYL ALCOHOL, LINOLEIC ACID, LINOLENIC ACID, RETINYL PALMITATE, TEPRENONE, ARTEMIA (PLANKTON) EXTRACT, BENZOIC ACID, HYDROXYETHYLCELLULOSE, CARBOMER, POLYSORBATE 20, SORBIC ACID, CITRUS AURANTIUM (NEROLI), PALMITOYL OLIGOPEPTIDE, PALMITOYL TETRAPEPTIDE-7
Package Label Section
BRITE PREP FX BRIGHTENING FOUNDATION PRIMER SPF 50
30 mL/1.0 FL OZ e CREAM
DERMATOLOGISTS FIRST CHOICE
CRUELTY FREE
SUSTAINABLE FORESTRY INITIATIVE Certified Chain of Custody Promoting Sustainable Forest Management www.sfiprogram.org
COVER FX DIST. BY/ COVER FX SKIN CARE INC. TORONTO, ONTARIO CANADA M3J 2W8. LONDON W1V 2LD WWW.COVERFX.COM
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c6f86816-7da6-43ea-8c25-ac9758311cc5 | Product name | 1 | 20220118 |
| 252e11b6-1a9a-4283-a242-df2c129c496d | Product name | 3 | 20170717 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68327-005-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0bd3-f424-e053-dadaa90a57ce | df0af55f-f2af-4786-bbb3-5bc59570b3f2 |
| 68327-005-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0bd3-f424-e053-dadaa90a57ce | df0af55f-f2af-4786-bbb3-5bc59570b3f2 |
| 68327-005-03 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0bd3-f424-e053-dadaa90a57ce | df0af55f-f2af-4786-bbb3-5bc59570b3f2 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68327-005-01 | BritePrep FX | 30 mL in 1 TUBE | CREAM | 30 | 1 | |
| 68327-005-02 | BritePrep FX | 15 mL in 1 TUBE | CREAM | 15 | 1 | |
| 68327-005-03 | BritePrep FX | 5 mL in 1 TUBE | CREAM | 5 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| OCTOCRYLENE | ACTIVE INGREDIENT | 5A68WGF6WM | 1 | |
| OXYBENZONE | ACTIVE INGREDIENT | 95OOS7VE0Y | 1 | |
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| OCTOCRYLENE | ACTIVE MOIETY | 5A68WGF6WM | 1 | |
| OXYBENZONE | ACTIVE MOIETY | 95OOS7VE0Y | 1 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| ALKYL (C12-15) BENZOATE | INACTIVE INGREDIENT | A9EJ3J61HQ | 1 | |
| ALOE VERA LEAF | INACTIVE INGREDIENT | ZY81Z83H0X | 1 | |
| ALPHA-TOCOPHEROL ACETATE | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| ALUMINUM OXIDE | INACTIVE INGREDIENT | LMI26O6933 | 1 | |
| ARCTOSTAPHYLOS UVA-URSI LEAF | INACTIVE INGREDIENT | 3M5V3D1X36 | 1 | |
| ASCORBYL GLUCOSIDE | INACTIVE INGREDIENT | 2V52R0NHXW | 1 | |
| BENZOIC ACID | INACTIVE INGREDIENT | 8SKN0B0MIM | 1 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | 1 | |
| BRINE SHRIMP | INACTIVE INGREDIENT | 3ID50N77DH | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | INACTIVE INGREDIENT | 4Q93RCW27E | 1 | |
| CETYL PEG/PPG-10/1 DIMETHICONE (HLB 3.7) | INACTIVE INGREDIENT | 8INO2K35FA | 1 | |
| CITRUS AURANTIUM FLOWER OIL | INACTIVE INGREDIENT | D4BGE91OXH | 1 | |
| CYCLOMETHICONE 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| DIMETHICONE/DIENE DIMETHICONE CROSSPOLYMER | INACTIVE INGREDIENT | RSA9I561OK | 1 | |
| DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) | INACTIVE INGREDIENT | 9E4CO0W6C5 | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| GLYCERYL 1,2-DIBEHENATE | INACTIVE INGREDIENT | 21E45121YS | 1 | |
| HIGH DENSITY POLYETHYLENE | INACTIVE INGREDIENT | UG00KM4WR7 | 1 | |
| HYDROGENATED POLYBUTENE (1300 MW) | INACTIVE INGREDIENT | 7D1YQ9Y5EZ | 1 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | 1 | |
| ISOPROPYL TITANIUM TRIISOSTEARATE | INACTIVE INGREDIENT | 949E3KBJ1I | 1 | |
| LEVOMENOL | INACTIVE INGREDIENT | 24WE03BX2T | 1 | |
| LINOLEIC ACID | INACTIVE INGREDIENT | 9KJL21T0QJ | 1 | |
| LINOLENIC ACID | INACTIVE INGREDIENT | 0RBV727H71 | 1 | |
| MEDIUM-CHAIN TRIGLYCERIDES | INACTIVE INGREDIENT | C9H2L21V7U | 1 | |
| MICA | INACTIVE INGREDIENT | V8A1AW0880 | 1 | |
| OCTADECENEDIOIC ACID | INACTIVE INGREDIENT | 565ZMT5QRG | 1 | |
| PALMITOYL OLIGOPEPTIDE | INACTIVE INGREDIENT | HO4ZT5S86C | 1 | |
| PALMITOYL TETRAPEPTIDE-7 | INACTIVE INGREDIENT | Q41S464P1R | 1 | |
| POLYHYDROXYSTEARIC ACID (2300 MW) | INACTIVE INGREDIENT | YXH47AOU0F | 1 | |
| POLYSORBATE 20 | INACTIVE INGREDIENT | 7T1F30V5YH | 1 | |
| SHEA BUTTER | INACTIVE INGREDIENT | K49155WL9Y | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| SORBIC ACID | INACTIVE INGREDIENT | X045WJ989B | 1 | |
| SQUALANE | INACTIVE INGREDIENT | GW89575KF9 | 1 | |
| STANNIC OXIDE | INACTIVE INGREDIENT | KM7N50LOS6 | 1 | |
| TEA LEAF | INACTIVE INGREDIENT | GH42T47V24 | 1 | |
| TEPRENONE | INACTIVE INGREDIENT | S8S8451A4O | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| TRIBEHENIN | INACTIVE INGREDIENT | 8OC9U7TQZ0 | 1 | |
| TRIETHOXYCAPRYLYLSILANE | INACTIVE INGREDIENT | LDC331P08E | 1 | |
| VITAMIN A PALMITATE | INACTIVE INGREDIENT | 1D1K0N0VVC | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- BritePrep FX
- OCTOCRYLENE, OCTINOXATE, OXYBENZONE,TITANIUM DIOXIDE
- OCTOCRYLENE
- OCTINOXATE
- OXYBENZONE
- TITANIUM DIOXIDE
- CYCLOMETHICONE 5
- WATER
- HYDROGENATED POLYBUTENE (1300 MW)
- GLYCERIN
- HIGH DENSITY POLYETHYLENE
- MEDIUM-CHAIN TRIGLYCERIDES
- ALKYL (C12-15) BENZOATE
- TEA LEAF
- SILICON DIOXIDE
- DIMETHICONE/DIENE DIMETHICONE CROSSPOLYMER
- CETYL PEG/PPG-10/1 DIMETHICONE (HLB 3.7)
- SQUALANE
- MICA
- GLYCERYL 1,2-DIBEHENATE
- ALOE VERA LEAF
- ASCORBYL GLUCOSIDE
- LEVOMENOL
- SHEA BUTTER
- DIMETHICONE
- OCTADECENEDIOIC ACID
- ALPHA-TOCOPHEROL ACETATE
- SODIUM CHLORIDE
- BUTYLENE GLYCOL
- TRIBEHENIN
- DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE)
- STANNIC OXIDE
- ALUMINUM OXIDE
- ARCTOSTAPHYLOS UVA-URSI LEAF
- ISOPROPYL TITANIUM TRIISOSTEARATE
- POLYHYDROXYSTEARIC ACID (2300 MW)
- BENZYL ALCOHOL
- LINOLEIC ACID
- LINOLENIC ACID
- VITAMIN A PALMITATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 68327-005 | 68327-005-01, 68327-005-02, 68327-005-03 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CREAM / TOPICAL | 80 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | MOUTHWASH / BUCCAL | NA | ||
| SQUALANE | SQUALANE | GW89575KF9 | CREAM, AUGMENTED / TOPICAL | 120 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | 990.3 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | SUPPOSITORY / RECTAL | 129 mg | ||
| SORBIC ACID | SORBIC ACID | X045WJ989B | TABLET, CHEWABLE / ORAL | NA | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / IONTOPHORESIS | 0.6 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET, ORALLY DISINTEGRATING / ORAL | 10 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | AEROSOL, FOAM / TOPICAL | 1 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TAMPON / VAGINAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | TAMPON / VAGINAL | 64.8 mg | ||
| HIGH DENSITY POLYETHYLENE | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | JELLY / VAGINAL | 42.6 %w/w | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | SUSPENSION, EXTENDED RELEASE / ORAL | 70 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION / INTRAMUSCULAR | 1.62 %w/v | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | SUSPENSION / ORAL | 80 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | 750 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET, FILM COATED / ORAL | 100 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION, SOLUTION / SUBCUTANEOUS | 0.95 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAOCULAR | 320 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 144 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION, CONCENTRATE / INTRAVENOUS | 0.86 %w/v | ||
| HIGH DENSITY POLYETHYLENE | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | TABLET, COATED / ORAL | 25 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOAP / TOPICAL | 1.26 %w/w | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION, SOLUTION / INTRAVENOUS | 30 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / ORAL | 602 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, LIQUID FILLED / ORAL | 12 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | CAPSULE / ORAL | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / RESPIRATORY (INHALATION) | 108 mg | ||
| SORBIC ACID | SORBIC ACID | X045WJ989B | TABLET / SUBLINGUAL | 0.16 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRADERMAL | 7 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRAMUSCULAR | 1486 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVERNOUS | 18 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | SOLUTION / ORAL | 5566 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | SUSPENSION / TOPICAL | 1 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | CREAM / TOPICAL | 6 mg | ||
| CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | EMULSION / TOPICAL | 6 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | SUSPENSION / AURICULAR (OTIC) | 0.9 %w/v | ||
| ALUMINUM OXIDE | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 0.68 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | JELLY / NASAL | NA | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | CONCENTRATE / ORAL | 12.5 mg/5ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | TABLET / ORAL | 1.06 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | ENEMA / RECTAL | 0.7 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / OPHTHALMIC | 55 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / OPHTHALMIC | 13 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | DROPS / ORAL | NA | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | LOTION / TOPICAL | 0.2 %w/w | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | AEROSOL, FOAM / TOPICAL | 3.7 %w/w | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | CAPSULE / ORAL | 4771 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION, CONCENTRATE / INTRAMUSCULAR | 0.86 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 048bb7e5-b132-4b36-8274-8c8db1c1fb07 | df0af55f-f2af-4786-bbb3-5bc59570b3f2 | 2013-02-19 | Warnings | 048bb7e5-b132-4b36-8274-8c8db1c1fb07 df0af55f-f2af-4786-bbb3-5bc59570b3f2 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.